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ScienceDirectDirected evolution allows the effective engineering of proteins,
biosynthetic pathways, and cellular functions. Traditional
plasmid-based methods generally subject one or occasionally
multiple genes-of-interest to mutagenesis, require time-
consuming manual interventions, and the genes that are
subjected to mutagenesis are outside of their native genomic
context. Other methods mutagenize the whole genome
unselectively which may distort the outcome. Recent
recombineering- and CRISPR-based technologies radically
change this field by allowing exceedingly high mutation rates at
multiple, predefined loci in their native genomic context. In this
review, we focus on recent technologies that potentially allow
accelerated tunable mutagenesis at multiple genomic loci in
the native genomic context of these target sequences. These
technologies will be compared by four main criteria, including
the scale of mutagenesis, portability to multiple microbial
species, off-target mutagenesis, and cost-effectiveness.
Finally, we discuss how these technical advances open new
avenues in basic research and biotechnology.
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Introduction
On a sufficiently long timescale with a large enough
population size, biological evolution can produce myriad
intricate solutions to various selective pressures. Over
time, the best performing genetic variants are continu-
ously selected resulting in highly specialized geneCurrent Opinion in Microbiology 2020, 57:22–30 products with optimal properties. Humans have long
sought to speed up and control this process to produce
whole organisms or specific biomolecules with desired
traits [1]. With the advent and continuing advancement of
molecular biological techniques, efforts to direct evolu-
tion have greatly increased in specificity, capable of
targeting single genes within organisms [2,3]. The con-
current development of highly efficient methods for the
screening of gene variant libraries [4,5] has allowed for the
isolation of a range of enzymes with improved or
completely novel functions [6].
The most comprehensive approach for achieving these
objectives requires saturation mutagenesis, that is, the
ability to generate and screen all possible amino acid
variants and their combinations at as many positions of a
protein as possible. Although a variety of techniques have
long existed capable of generating gene variant libraries
towards this goal, recent years have seen the development
of more refined mutagenesis technologies with increased
targeting precision, increased ranges of attainable muta-
tion rates, and decreased biases in mutational spectra. We
briefly summarize these most recent advances and their
related applications, focusing on tools developed and
employed in microbial systems. These technologies
can be broadly categorized based on whether the muta-
genized target DNA is on an extrachromosomal element
or on genomic DNA. While the former is more amenable
to a wide variety of highly precise strategies, which allow
for true saturation, the latter allows probing the effects of
mutations in their truly native contexts by coupling the
mutation generation and variant selection steps. Finally,
we highlight recent approaches that are overcoming these
limitations of mutagenesis of user-defined chromosomal
segments and offer new possibilities for both fundamen-
tal evolutionary biology questions, as well as industrial
applications.
Extrachromosomal mutagenesis
Extrachromosomal mutagenesis methods have the inher-
ent ability of focusing the generation of genetic variants to
a specified segment of DNA, allowing for saturation
studies of selected regions of interest. However, these
libraries are generated separately from the functional
selection process and require labor-intensive cloning
and transformation steps that often present a limit to
the final number of variants that are screened. The most
long-standing such method has been error-prone PCR [7],
which makes use of the low fidelity of DNA polymerases
under certain conditions. This approach has long beenwww.sciencedirect.com
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attain novel variants for example, with new catalytic
activities [8], improved stability [9], or novel binding
capabilities [10]. Drawbacks of error-prone PCR methods
include relatively low per base mutation rates and inher-
ently biased mutational spectra making it impossible to
achieve saturation [11]. Improvements to overcome these
limitations have been made in techniques such as
‘sequence saturation mutagenesis’ where a universal base
is inserted throughout the target sequence [12] and also in
‘casting error-prone PCR’, where target sequences are
divided up into smaller fragments [13], making for higher
levels of mutational coverage.
A more targeted PCR-based approach that allows for true
saturation of selected positions but generates variants of
much shorter sequences, is site saturation mutagenesis
(SSM), which utilizes synthetic oligonucleotides carrying
one or more degenerate codon (such as NNK). To
increase efficiency of this approach, prior identification
of key residues of the given gene-product through phy-
logenetic analysis of homologous proteins is usually per-
formed, and regions deemed important for functionality
are then targeted. Numerous variations of this technique
exist, the most common being QuikChange mutagenesis
[14] where overlapping oligonucleotides carrying the
degenerate codons are used to amplify the target
sequence from a plasmid. Recent variations of SSM
include nicking mutagenesis [15] and mutagenesis with
reversibly terminated deoxyinosine triphosphates [16],
both of which allowed for comprehensive saturation
libraries of the active sites of the bla gene in Escherichia
coli encoding TEM-1 b; as well as a two-step PCR
strategy applicable to difficult-to-randomize genes [17].
SSM has numerous applications, including the engineer-
ing of protein binding and selectivity [18], increased
enzymatic activity [19], or enhanced therapeutic efficacy
[20]. Most recently, SSM was utilized for the mutagenesis
of phage tail fiber residues, limiting bacterial phage
resistance, thereby increasing efficiency of phage therapy
[21].
Recent advances in DNA synthesis capabilities have
allowed the massively parallel in vitro generation of gene
variant libraries by high-throughput oligo synthesis [22].
Although such oligos are limited in size (350 nucleotide
maximal length), this has enabled complete saturation
mutagenesis of short genes, including a tRNA gene in
yeast [23]. Recently, tiling of multiple (19 in this case)
such oligonucleotide libraries allowed for the generation
of the complete first-order fitness landscape of a much
larger adeno-associated virus capsid gene [24]. The high
cost of DNA synthesis has been an obstacle in generating
large gene variant libraries in this fashion, however tech-
niques such as DropSynth, an emulsion-based DNA
synthesis method [25] hold promise in making this
approach more attainable.www.sciencedirect.com Several methodologies also exist for mutating episomal
target genes in a continuous manner, which has the
advantage of not requiring prior in vitro synthesis of
variants of PCR-based or synthesis-based approaches.
Many of these techniques utilize error-prone (EP)
variants of DNA polymerases for replicating plasmid
DNA leading to mutagenesis of the target sequence.
This was originally achieved by transforming the vector
into a mutator host strain with EP DNA polymerase
enzymes and defective/deleted mismatch-repair sys-
tems such as E. coli strain XL1-Red [26]. However,
the systematically high mutation rates of such strains
eventually lead to deleterious effects in the cell, slow-
ing growth and making the cells difficult to transform. A
more targeted approach utilizes an EP DNA polymer-
ase I (Pol I) enzyme to mutagenize the cargo of a Pol I-
dependent plasmid [27]. A more refined version of this
principle was developed recently in yeast termed
OrthoRep, where the replication of a plasmid carrying
the targeted DNA sequence is fully dependent upon an
engineered orthologous EP DNA polymerase that oth-
erwise does not replicate the host genome or other
plasmids [28]. This system allowed the generation
of a detailed  fitness landscape of the malarial dihydro-
folate reductase against the anti-malarial drug pyri-
methamine. An entirely different approach utilizes
bacteriophage and their lifecycles as vessels for muta-
genizing a target gene. In phage-assisted continuous
evolution (PACE), propagation of the M13 bacterio-
phage relies on bacterial production of the pIII infec-
tivity protein, which in turn is dependent on functional
library variants encoded within the phage. In this fash-
ion, genes of interest can be encoded on M13 and
continuously mutagenized to rapidly generate satura-
tion libraries. PACE was recently employed to evolve
Bacillus thuringiensis d-endotoxin variants able to target
previously resistant insect pests [29], to generate a
variety of proteins with improved soluble expression
[30], and to evolve Cas9 variants with altered PAM
specificity and higher precision [31].
Genomic strategies
Targeting chromosomal DNA sequences for mutagen-
esis has the advantages of eliminating labor-intensive
cloning and PCR steps and coupling the variant gener-
ation and selection steps, all while maintaining the
native genetic context of the target. The first
approaches aiming to generate chromosomal gene vari-
ant libraries utilized various DNA damaging forces or
compounds affecting the entire chromosome of an
organism. A range of both physical (e.g. ultraviolet
irradiation, gamma rays) and chemical (e.g. ethyl
methanesulfonate, nitrous acid) mutagens induce
mutations at random sequences throughout the genome
[32] and can be utilized for genome-wide gene inacti-
vation screens.Current Opinion in Microbiology 2020, 57:22–30
24 Microbial system biologyChemical mutagenesis protocols are conceptually simple
and broadly applicable, but hey have associated health
hazards, and the associated mutational spectra are gener-
ally biased. In a similar vein, a mutagenesis plasmid (MP)
approach has been developed, where selected dominant
mutator genes are expressed from a vector in the bacteria
of interest, leading to a systematic increase in mutation
rates with less bias in the mutational spectra than physical
and chemical approaches [33]. Overall, mutator strains
and chemical mutagenesis do not require specification of
the genomic regions relevant for the selected phenotype:
they increase overall bacterial genomic mutation rate. As
a consequence, they cannot be focused to specific regions
for in-depth saturation studies, and result in deleterious
off-target effects.
Alternatively, synthetic constructs can be genomically
integrated to achieve targeted mutagenesis in a continu-
ous fashion. In one approach dubbed in vivo continuous
evolution (ICE), retroelements are constructed in yeast to
encode a targeted gene of interest which undergoes EP
reverse-transcription and genomic integration in a con-
tinuous fashion [34]. In another approach, an array of
specific sites can be genomically integrated next to a
selected region of interest to which a glycosylase enzyme
is recruited that is capable of mutagenizing a 20 kb
genomic region [35]. These approaches solve the problem
of localizing mutagenesis within the genome, however






















Schematic representation of microbial genome editing methods capable of 
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MAGE, MAGE-Seq, MO-MAGE, and eMAGE utilize single-stranded DNA oli
into the genomic target. (b) TMMR achieves the same outcome by recombi
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Current Opinion in Microbiology 2020, 57:22–30 resulting in considerable modifications to the native
contexts.
Targeted mutagenesis of multiple genomic loci
Recent years have seen the development of a number of
diverse strategies that all aim to combine the high preci-
sion of extrachromosomal mutagenesis with genomic
targeting for the saturation mutagenesis of specified
genomic sequences within their native contexts. Two
key technologies have enabled these advances: the devel-
opment and optimization of single-stranded oligonucleo-
tide-based recombineering methods [36], and the advent
of CRISPR-Cas genome engineering technologies [37].
These approaches allow for unprecedented precision in
the targeted modification of microbial genomes, and,
through various strategies, can be adapted to mutagenize
distinct chromosomal regions (Figure 1 and Table 1).
Recombineering-based approaches rely on the annealing of
synthetic single-stranded oligonucleotides to the lagging
strands at open replication forks. This process requires
specific single-stranded DNA annealing proteins (e.g.
the phage l’s Red Beta protein for E. coli [38] or other
RecT variants [39]) to work at a high efficiency in a given
organism. In a landmark paper, recombineering was devel-
oped to introduce multiple mutations across the genome in
a process called multiplex automated genome engineering
(MAGE) [40]. 20 separate oligonucleotides containing
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targeted saturation genome-mutagenesis. Recombineering-based
e-stranded DNA cassette-mediated homologous recombination. (a)
gonucleotides that carry user-defined mutations and incorporate those
ning selectable dsDNA cassettes, that carry the desired modification,
 that carry randomly distributed random point-mutations along their
g on Cas9-induced double-stranded breaks plus homologous
R-Cas9-induced DSBs to select the integration of an editing DNA
d Cas9- (dead(d)- or nicking(n)-) guided methods exploit Cas9’s ability
roximity of a Cas9-fused mutator enzyme and thus introduce desired
an extended description of each method.
www.sciencedirect.com
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Table 1
Efficacy and costs of targeted mutagenesis methods
Basis of
technology





Up to 30 nucleotides using a
single oligo or hundreds of
nucleotides (e.g. 219 of
essential gene infA) in parallel
using multiple oligos (1 per
12 saturated codons)





deficient strain required for










target up to 30 bp
TRMR [41] Thousands of nucleotides in
parallel using multiple oligos




MO-MAGE [44] Thousands of nucleotides in
parallel using multiple oligos
Optimized for E. coli High, MMR deficient strain
required for high efficiency




Eukaryotic MAGE [48] Hundreds of nucleotides in
parallel using multiple oligos,
constrained by requirement




High, MMR deficient strain






target up to 30 bp
DIvERGE [47] Thousands of nucleotides in
parallel using multiple oligos
Optimized for E. coli,
applicable to a range
of Enterobacteriacae







target up to 72 bp
Cas9-induced
DSB, HDR
CREATE [53] Thousands of nucleotides in
parallel using multiple repair
cassettes




expected to be low
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Maximum of 2 parallel targets
demonstrated, mutagenesis
limited to 100 nucleotides
surrounding PAM-
constrained target site, high
bias in mutational spectra
E. coli, S. cerevisiae,
human cells






EvolvR [64] Targeting of 2 parallel targets
demonstrated, mutagenesis
limited to 50350 nucleotides
in vicinity of PAM-constrained
target site with declining
mutagenesis with increased
distance









mutagenesissimultaneously targeted to various genes all involved in the
biosynthesis of lycopene, leading to a fivefold increase in
the production of this industrially relevant isoprenoid com-
pound in only three days. In a method termed trackable
multiplex recombineering, the MAGE approach was fur-
ther refined to include barcodes within each oligonucleo-
tide to allow for massively parallel mutagenesis of multiple
genomic regions and the subsequent identification of mod-
ified sequences that resulted in improved phenotypes of
interest [41]. This approach allowed for the mutagenesis ofwww.sciencedirect.com the RBSs of close to all genes in E. coli to modify their
expression levels allowing improved growth in various
environments [42]. MAGE can be employed in a highly
focused manner, as synthesizing a library of oligonucleo-
tides each carrying a degenerate codon of the same gene,
allowed for the saturation codon mutagenesis of the essen-
tial gene infA in E. coli [43]. Measuring the fitness of each
individual variant, combined with amplicon deep sequenc-
ing, enabled the in-depth analysis of the effects of codon
usage across an entire gene.Current Opinion in Microbiology 2020, 57:22–30
26 Microbial system biologyIn order to scale up the mutagenizing capabilities of
MAGE to allow for potential saturation of extended
genomic targets and enhanced multiplexability, micro-
array-oligonucleotide (MO)-MAGE was developed,
where the mutation-inducing oligos are synthesized from
microarray chips, allowing for parallel synthesis of large
(>55 000) libraries [44]. Alternatively, the introduction of
exogenous oligos to generate variants may be circum-
vented through a retroelement-based approach where a
mutagenic T7 RNA polymerase enzyme generates var-
iants of a sequence encoded on a retroelement in a
continuous manner [45]. A specialized reverse transcrip-
tase ultimately generates variants of single-stranded
DNA which then edits the target sequence through
ssDNA-recombineering.
A key drawback of MAGE-based recombineering
approaches is the requirement of a mismatch repair
(MMR)-deficient host for high efficiency mutagenesis.
This leads to a high background mutation rate, leading to
several off-target mutations, potentially confounding the
phenotypic effects of saturation mutagenesis of
the targeted region. One solution to this obstacle is
the utilization of counter-selection markers such as
the tetA-sacB system [46] or a system employing ccdB
[47]. Through a two-step recombination process, the
counter-selectable markers are integrated at the genomic
site of interest, which is subsequently targeted using
mutagenizing oligos. Counter-selection allows enrich-
ment of cells which have incorporated the mutagenizing
oligos all without the requirement of MMR inactivation.
Alternatively, a simplified approach dubbed portable,
plasmid-based MAGE (pORTMAGE) was developed,
which utilizes inducible expression of a dominant nega-
tive MMR protein allele to achieve high efficiency
recombineering while eliminating off-target effects
[48]. Building on this advance, it became possible to
specifically target extended genomic regions for satura-
tion mutagenesis without any detectable off-target
effects. This was achieved in a method called directed
evolution with random genomic mutations (DIvERGE),
which utilizes pools of oligonucleotides synthesized
using a soft-randomization protocol (where the
alternative nucleotides are spiked in at low (0.5–2%)
amounts) at each nucleotide position [49]. Such a
synthesis approach significantly reduces the oligonucle-
otide costs of other methods such as MO-MAGE. The
tiling of such 90mer oligos allows for the coverage of
entire chromosomal genes for saturation mutagenesis.
DIvERGE simultaneously targets multiple, user-
defined regions, up to 10 s of kilobases in total, and
has broad, controllable mutagenesis spectra for each
nucleotide position [49]. Importantly, DIvERGE is
applicable to a range of bacterial host species without
the need for prior genomic modification and off-target
mutagenesis rate is expected to be very low [49].
DIvERGE was utilized to perform simultaneousCurrent Opinion in Microbiology 2020, 57:22–30 combinatorial saturation mutagenesis of the 4 genes
(a total of 9.5 kb) encoding the target proteins of the
antibiotics ciprofloxacin and gepotidacin [39,49], while
saturation mutagenesis of the target gene for the drug
trimethoprim resulted in combinations of 5 mutations
showing a >3900-fold increase in drug resistance [49].
Overall, recombineering-based approaches now allow for
the most extensive and controllable mutagenesis of
multiple chromosomal regions in microbes, opening
entirely new possibilities for future applications (see
future perspectives).
Despite these unmatched capabilities, recombineering-
based approaches do have some inherent limitations.
Recombineering relies on active replication forks
within the target cell, meaning the slower division time
of eukaryotes makes the approach less efficient [50].
Also, ssDNA annealing proteins are not universal in
their efficiencies in diverse bacterial organisms, mean-
ing specific systems have to be optimized for different
species [39, 51–53,68]. Finally, it generally relies on the
in vitro synthesis of oligonucleotides to generate diver-
sity. The advent of CRISPR-Cas-based gene editing
technologies has offered solutions to some of these
limitations. Double-stranded breaks of chromosomal
DNA greatly enhance the recombination frequency
of introduced homologous templates. Repurposed
CRISPR-based systems (generally employing Cas9)
can specifically cleave a genomic sequence of interest,
leading to a vast improvement in the frequency of
edited microbial cells [54]. Combining this capability
with large-scale oligonucleotide  synthesis led to the
development of CRISPR-enabled trackable genome
engineering (CREATE), which utilizes  pools of 104–
106 barcoded oligos to achieve genomic mutagenesis at
chromosomal sites in bacteria [55]. A number of similar
approaches were recently developed in yeast
[56,57,58,59,60,61], demonstrating the expanded
potential of CRISPR-based targeted mutagenesis
approaches in eukaryotes (see Box 1 for specific appli-
cations of these technologies).
All of these CRISPR-based methods require the prior
synthesis of large pools of DNA oligonucleotides which
serve as the editing templates for gene variation gener-
ation. Fusing various mutagenizing enzymes to a cata-
lytically inactive version of Cas9 (dCas9) allows for
their targeted localization within the genome, allowing
for highly specific mutagenesis. One such approach
utilizes fusion [62] or recruitment [63] of activation-
induced cytidine deaminase (AID) to dCas9 to generate
targeted mutagenesis specified by the single guide
RNA (sgRNA) sequences. Using multiple sgRNAs
allowed for tiling of longer mutagenized sequences
and was used to identify drug resistance mutations
against various cancer therapeutics in mammalian cells
[62,63]. A similar approach fused AID to zinc-finger andwww.sciencedirect.com
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Box 1 Current applications of CRISPR-based mutagenizing
technologies
CRISPR-enabled trackable genome engineering (CREATE) combines
the genome editing capabilities of CRISPR-Cas9 with large-scale
DNA oligo synthesis to achieve targeted chromosomal mutagenesis
in bacteria [55]. This approach was used to saturate all codons of the
folA drug-target gene in E. coli, and identify all resistance conferring
individual mutations. CREATE can be used in multiplex, and was
used to target 50 000 genomic sites to select for variants with
improved tolerance to temperature and to the industrial solvents
furfural and acetate [55]. CREATE can also be performed iteratively,
generating combinations of thousands of mutations to achieve 60-
fold improvement in the production of the industrially important
chemical 3-hydroxypropionic acid [66]. The technique has also been
used for the parallel mutagenesis of 19 genes involved in lysine
metabolism in E. coli, identifying determinants capable of increasing
production of the metabolite [67]. Building upon the basic principles
laid down by CREATE, several methods have been recently devel-
oped to expand these capabilities to eukaryotes as well. These
approaches have allowed the genomic integration of large libraries of
variants and have enabled a wide variety of applications, including:
determining the functional consequences of premature-termination
codons at various locations within all annotated essential genes
[57], the saturation mutagenesis of a 29 amino acid region of the
Siz1 protein for increased tolerance to the growth-inhibitor furfural
[58], the saturation editing of the essential gene SEC14 and identi-
fication of amino acids critical for chemical inhibition of lipid signaling
[59], the generation of a set of tiling deletion mutants for charac-
terization of the SGS1 DNA helicase enzyme [60], the generation and
screening of combinations of mutations in two key enzymes of the
mevalonate pathway resulting in improved isoprenoid production
[61], and studying the fitness consequences of 16 006 natural
genetic variants through a retroelement-based approach to generate
variation [62].transcription activator-like effector proteins to achieve
targeted variant generation in E. coli [64]. Finally, a
CRISPR-guided Cas9 nickase was recently used to
guide an engineered EP nick-translating DNA poly-
merase to specific genomic target sites, raising mutation
rate by 3–4 orders of magnitude compared to back-
ground levels [65]. This system, termed EvolvR is
capable of generating all single substitutions in a 60-
nucleotide window after 16 hours in 1 ml of saturated
culture. Notwithstanding certain limitations of existing
CRISPR-guided targeted genomic mutagenesis tools
such as biases in mutational spectra, potential off-target
effects, limited targeting window size, and an increased
background mutation rate in the case of EvolvR, these
technologies hold great promise in potential applica-
tions going forward.
Future perspectives for in vivo chromosomal
saturation mutagenesis
The technologies currently allowing for the most con-
trolled and complete mutagenesis of chromosomal
sequences of interest (such as DIvERGE [49], CRE-
ATE [55], and EvolvR [65]) will open new doors in
what is possible in directed evolution. Broadly, examples
of these future applications include: (1) Targetedwww.sciencedirect.com mutagenesis along the full length of multiple genes
within a genome. This will allow the engineering of novel
cellular functions involving multiple proteins, such as
evolving novel metabolic functions from complex path-
ways. (2) Metabolic engineering in previously under-
utilized species. These above techniques can be adapted
to a range of bacteria, including those with untapped
metabolic potential resulting in optimization of novel
industrially relevant pathways. (3) Saturation mutagene-
sis of multiple genes, allowing the directed evolution of
multiprotein complexes. Improvement of complex traits
often requires co-evolution of interacting amino acids
coded at distinct loci, whose mutations provide no ben-
efits individually. (4) Forecasting the dynamics of resis-
tance evolution to novel antimicrobial drugs. System-
wide mutagenesis affecting gene expression levels will
aid in identifying primary drug targets and mechanisms of
action. Once these are identified, saturation mutagenesis
of the encoding genes will allow detailed fitness land-
scapes in the presence of a given drug. (5) Optimization of
in vitro synthesized DNA constructs. In vitro constructed
DNA elements encoding for example, biosynthetic path-
ways, genetic circuits, or entire genomic segments often
lack clear design principles thus leading to suboptimal
performance. High-throughput variant generation of the
constructs will lead to rapid optimization. Finally, (6)
fundamental evolutionary biology questions, such as
the conservation of epistatic effects between related
species or the phenotypic effects of varying codon usage
in different species could be studied in greatly enhanced
detail.
In summary, the last several years have seen great
strides in the ability to generate genetic variant libraries
capable of saturation of selected sequences. Many of
these techniques can complement each other and
depending on the studied organism, the level of speci-
ficity, targeting window size, and level of saturation, the
ideal strategy can be chosen for a range of diverse
applications.
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Engineered CRISPR-Cas12a variants with increased activities
and improved targeting ranges for gene, epigenetic and base
editing. Nat Biotechnol 2019, 37:276-282.Current Opinion in Microbiology 2020, 57:22–30 20. Whitehead TA, Chevalier A, Song Y, Dreyfus C, Fleishman SJ,
Mattos CD, Myers CA, Kamisetty H, Blair P, Wilson IA et al.:
Optimization of affinity, specificity and function of designed
influenza inhibitors using deep sequencing. Nat Biotechnol
2012, 30:543-548.
21. Yehl K, Lemire S, Yang AC, Ando H, Mimee M, Torres MDT, de la
Fuente-Nunez C, Lu TK: Engineering phage host-range and
suppressing bacterial resistance through phage tail fiber
mutagenesis. Cell 2019, 179:459-469.e9.
22. Rocklin GJ, Chidyausiku TM, Goreshnik I, Ford A, Houliston S,
Lemak A, Carter L, Ravichandran R, Mulligan VK, Chevalier A
et al.: Global analysis of protein folding using massively
parallel design, synthesis, and testing. Science 2017,
357:168-175.
23. Li C, Qian W, Maclean CJ, Zhang J: The fitness landscape of a
tRNA gene. Science 2016, 352:837-840.
24. Ogden PJ, Kelsic ED, Sinai S, Church GM: Comprehensive AAV
capsid fitness landscape reveals a viral gene and enables
machine-guided design. Science 2019, 366:1139-1143.
25.

Plesa C, Sidore AM, Lubock NB, Zhang D, Kosuri S: Multiplexed
gene synthesis in emulsions for exploring protein functional
landscapes. Science 2018, 359:343-347.
This work introduces DropSynth, a scalable, low-cost, droplet-based
method to construct 1000s of gene-length assemblies simultaneously.
The authors applied DropSynth to successfully build more than 7000 syn-
thetic, phylogenetically diverse homologs of two essential genes of E. coli
and tested their functionality in vivo.
26. Greener A, Callahan M, Jerpseth B: An efficient random
mutagenesis technique using an E. coli mutator strain. Mol
Biotechnol 1997, 7:189-195.
27. Camps M, Naukkarinen J, Johnson BP, Loeb LA: Targeted gene
evolution in Escherichia coli using a highly error-prone DNA
polymerase I. PNAS 2003, 100:9727-9732.
28.

Ravikumar A, Arzumanyan GA, Obadi MKA, Javanpour AA, Liu CC:
Scalable, continuous evolution of genes at mutation rates
above genomic error thresholds. Cell 2018, 175:1946-1957.e13.
The authors describe OrthoRep, an orthogonal, highly error-prone DNA
polymerase-plasmid pair in Saccharomyces cerevisiae that stably
mutates plasmid-borne sequences up to 100 000-fold faster than the
host genome. Using OrthoRep, the authors simultaneously evolved
antimalarial drug-resistant dihydrofolate reductases in 90 replicates.
29. Badran AH, Guzov VM, Huai Q, Kemp MM, Vishwanath P, Kain W,
Nance AM, Evdokimov A, Moshiri F, Turner KH et al.: Continuous
evolution of Bacillus thuringiensis toxins overcomes insect
resistance. Nature 2016, 533:58-63.
30. Wang T, Badran AH, Huang TP, Liu DR: Continuous directed
evolution of proteins with improved soluble expression. Nat
Chem Biol 2018, 14:972-980.
31. Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, Zeina CM,
Gao X, Rees HA, Lin Z et al.: Evolved Cas9 variants with broad
PAM compatibility and high DNA specificity. Nature 2018,
556:57-63.
32. Kodym A, Afza R: Physical and chemical mutagenesis. Methods
Mol Biol 2003, 236:189-204.
33. Badran AH, Liu DR: Development of potent in vivo mutagenesis
plasmids with broad mutational spectra. Nat Commun 2015,
6:8425.
34. Crook N, Abatemarco J, Sun J, Wagner JM, Schmitz A, Alper HS:
In vivo continuous evolution of genes and pathways in yeast.
Nat Commun 2016, 7.
35. Finney-Manchester SP, Maheshri N: Harnessing mutagenic
homologous recombination for targeted mutagenesis in vivo
by TaGTEAM. Nucleic Acids Res 2013, 41 e99–e99.
36. Thomason LC, Sawitzke JA, Li X, Costantino N, Court DL:
Recombineering: genetic engineering in bacteria using
homologous recombination: recombineering. In Current
Protocols in Molecular Biology. Edited by Ausubel FM, Brent R,
Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. John
Wiley & Sons, Inc.; 2014. 1.16.1-1.16.39.www.sciencedirect.com
Targeted chromosomal mutagenesis in microbes CsörgÅ, Nyerges and Pál 2937. Doudna JA, Charpentier E: The new frontier of genome
engineering with CRISPR-Cas9. Science 2014, 346:1258096.
38. Murphy KC: Use of bacteriophage l recombination functions
to promote gene replacement in Escherichia coli. J Bacteriol
1998, 180:2063-2071.
39. Wannier TM, Nyerges A, Kuchwara HM, Czikkely M, Balogh D,
Filsinger GT, Borders NC, Gregg CJ, Lajoie MJ, Rios X, Pál C,
Church GM: Improved bacterial recombineering by parallelized
protein discovery. Proc Natl Acad Sci 2020 http://dx.doi.org/
10.1073/pnas.2001588117.
40. Wang HH, Isaacs FJ, Carr PA, Sun ZZ, Xu G, Forest CR, Church GM:
Programming cells by multiplex genome engineering and
accelerated evolution. Nature 2009, 460:894-898.
41. Warner JR, Reeder PJ, Karimpour-Fard A, Woodruff LBA, Gill RT:
Rapid profiling of a microbial genome using mixtures of
barcoded oligonucleotides. Nat Biotechnol 2010, 28:856-862.
42. Sandoval NR, Kim JYH, Glebes TY, Reeder PJ, Aucoin HR,
Warner JR, Gill RT: Strategy for directing combinatorial
genome engineering in Escherichia coli. Proc Natl Acad Sci U S
A 2012, 109:10540-10545.
43. Kelsic ED, Chung H, Cohen N, Park J, Wang HH, Kishony R: RNA
structural determinants of optimal codons revealed by MAGE-
Seq. Cell Syst 2016, 3:563-571.e6.
44. Bonde MT, Kosuri S, Genee HJ, Sarup-Lytzen K, Church GM,
Sommer MOA, Wang HH: Direct mutagenesis of thousands of
genomic targets using microarray-derived oligonucleotides.
ACS Synth Biol 2014, 4:17-22.
45. Simon AJ, Morrow BR, Ellington AD: Retroelement-based
genome editing and evolution. ACS Synth Biol 2018, 7:2600-
2611.
46. Li X, Thomason LC, Sawitzke JA, Costantino N, Court DL: Positive
and negative selection using the tetA-sacB cassette:
recombineering and P1 transduction in Escherichia coli.
Nucleic Acids Res 2013, 41:e204.
47. Wang H, Bian X, Xia L, Ding X, Müller R, Zhang Y, Fu J, Stewart AF:
Improved seamless mutagenesis by recombineering using
ccdB for counterselection. Nucleic Acids Res 2014, 42:e37.
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